Apollo Endosurgery Inc
NASDAQ:APEN
Apollo Endosurgery Inc
Net Income (Common)
Apollo Endosurgery Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Apollo Endosurgery Inc
NASDAQ:APEN
|
Net Income (Common)
-$39.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-31%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Apollo Endosurgery Inc's Net Income (Common)?
Net Income (Common)
-39.8m
USD
Based on the financial report for Dec 31, 2022, Apollo Endosurgery Inc's Net Income (Common) amounts to -39.8m USD.
What is Apollo Endosurgery Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-31%
Over the last year, the Net Income (Common) growth was -61%. The average annual Net Income (Common) growth rates for Apollo Endosurgery Inc have been -13% over the past three years , -8% over the past five years , and -31% over the past ten years .